Dimopoulos MA - Search Results

1

Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.

Dimopoulos MA, Pouli A, Anagnostopoulos A, Repoussis P, Symeonidis A, Terpos E, Delimbasi S, Tsolakis F, Economopoulos T, Zervas C. Dimopoulos MA, et al. Leuk Lymphoma. 2006 Aug;47(8):1553-6. doi: 10.1080/10428190600647723. Leuk Lymphoma. 2006. PMID: 16966266

2

VAD-cyclosporine therapy for VAD-resistant multiple myeloma.

Weber D, Dimopoulos M, Sinicrope F, Alexanian R. Weber D, et al. Leuk Lymphoma. 1995 Sep;19(1-2):159-63. doi: 10.3109/10428199509059671. Leuk Lymphoma. 1995. PMID: 8574163 Clinical Trial.

3

Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome.

Michopoulos S, Petraki K, Petraki C, Dimopoulos MA. Michopoulos S, et al. Among authors: dimopoulos ma. Dig Dis Sci. 2002 Apr;47(4):730-4. doi: 10.1023/a:1014773512707. Dig Dis Sci. 2002. PMID: 11991600

4

Expansion of CD8+ T cells that express low levels of the B cell-specific molecule CD20 in patients with multiple myeloma.

Katopodis O, Liossis SN, Viglis V, Pouli A, Dimopoulos MA, Sfikakis PP. Katopodis O, et al. Among authors: dimopoulos ma. Br J Haematol. 2003 Feb;120(3):478-81. doi: 10.1046/j.1365-2141.2003.04087.x. Br J Haematol. 2003. PMID: 12580963 Free article.

5

Discordant response or progression in patients with myeloma treated with thalidomide-based regimens.

Anagnostopoulos A, Hamilos G, Zorzou MP, Grigoraki V, Anagnostou D, Dimopoulos MA. Anagnostopoulos A, et al. Among authors: dimopoulos ma. Leuk Lymphoma. 2004 Jan;45(1):113-6. doi: 10.1080/1042819031000151860. Leuk Lymphoma. 2004. PMID: 15061206

6

Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.

Anagnostopoulos A, Galani E, Gika D, Sotou D, Evangelopoulou A, Dimopoulos MA. Anagnostopoulos A, et al. Among authors: dimopoulos ma. Ann Hematol. 2004 Oct;83(10):658-60. doi: 10.1007/s00277-004-0896-1. Epub 2004 Jul 23. Ann Hematol. 2004. PMID: 15278296

7

Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors.

Anagnostopoulos A, Gika D, Hamilos G, Zervas K, Zomas A, Pouli A, Zorzou M, Kastritis E, Anagnostopoulos N, Tassidou A, Anagnostou D, Dimopoulos MA. Anagnostopoulos A, et al. Among authors: dimopoulos ma. Leuk Lymphoma. 2004 Nov;45(11):2275-9. doi: 10.1080/10428190410001733772. Leuk Lymphoma. 2004. PMID: 15512817

8

Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.

Koutsikos J, Athanasoulis T, Anagnostopoulos A, Velidaki A, Passadi M, Dimopoulos MA, Zerva C. Koutsikos J, et al. Among authors: dimopoulos ma. J Nucl Med. 2005 Jun;46(6):978-82. J Nucl Med. 2005. PMID: 15937309 Free article.

9

Multiple myeloma in elderly patients: prognostic factors and outcome.

Anagnostopoulos A, Gika D, Symeonidis A, Zervas K, Pouli A, Repoussis P, Grigoraki V, Anagnostopoulos N, Economopoulos T, Maniatis A, Dimopoulos MA. Anagnostopoulos A, et al. Among authors: dimopoulos ma. Eur J Haematol. 2005 Nov;75(5):370-5. doi: 10.1111/j.1600-0609.2005.00532.x. Eur J Haematol. 2005. PMID: 16191085

10

Rituximab therapy in monoclonal IgM-related neuropathies.

Kilidireas C, Anagnostopoulos A, Karandreas N, Mouselimi L, Dimopoulos MA. Kilidireas C, et al. Among authors: dimopoulos ma. Leuk Lymphoma. 2006 May;47(5):859-64. doi: 10.1080/14786410500441664. Leuk Lymphoma. 2006. PMID: 16753870 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,301 results

Search Page

Filters